Protai
Prof. Funda Meric-Bernstam has made internationally recognized contributions to precision oncology. As leader of one of the largest Phase I programs in the world, she has focused drug development on identifying single agents and combinations of drugs that target subsets of cancers from multiple sites with innovative basket trials.
This person is not in the org chart
This person is not in any offices
Protai
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.